Martin Olivier

McGill University - Department of Microbiology and Immunology

Canada

SCHOLARLY PAPERS

1

DOWNLOADS

16

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Engineering a Potent Cancer Vaccine Using Immunoproteasome-Expressing Mesenchymal Stromal Cells

Number of pages: 78 Posted: 09 Feb 2021
McGill University - Department of Microbiology and Immunology, University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Pharmacology and Physiology, Université de Montréal - Department of Biomedical Sciences, McGill University - Department of Microbiology and Immunology, University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Pharmacology and Physiology, University of Montreal - Department of Microbiology, Infectious Diseases and Immunology, Polytechnique Montréal - Research Laboratory in Applied Metabolic Engineering, Polytechnique Montréal - Research Laboratory in Applied Metabolic Engineering, University of Montreal - Department of Pharmacology and Physiology, Université du Québec à Montréal - Department of Chemistry, Université du Québec à Montréal - Department of Chemistry, McGill University - Department of Biochemistry, McGill University - Department of Biochemistry, University of Montreal - Department of Pharmacology and Physiology, University of Toronto - Department of Family and Community Medicine and University of Montreal - Department of Pharmacology and Physiology
Downloads 16 (655,869)

Abstract:

Loading...

Immunoproteasome, Mesenchymal Stromal Cells, Cancer Vaccine, SILACs, Transcriptomics, Metabolomics, Immunopeptidome, Immune-Checkpoint blockers, Universal Vaccine